Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
  • Midnight Wolf@lemmy.worldEnglish
    12·
    6 days ago

    I have high cholesterol. I can send you some if you want. Promise it will make you live longer, it says so on this lemmy comment…